Previous 10 | Next 10 |
-- Industry veteran with over than two decades of experience in medical affairs to lead clinical and medical affairs at Femasys -- ATLANTA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company developing a suite of product candidates to transform wome...
Completed initial public offering (“IPO”) raising net proceeds of $31.6 million Appointed Anne Morrissey to the Board of Directors, an industry expert with decades of medical device experience Initiated 792-patient, pivotal LOCAL trial after receipt of inve...
Gainers: NeuroMetrix NURO +233%.NeuroBo Pharmaceuticals NRBO +92%.Staffing 360 Solutions (STAF) +38%.LSB Industries (LXU) +36%.Femasys (FEMY) +27%.Ideal Power (IPWR) +26%.Endo International plc ENDP +25%.PainReform (PRFX) +21%.LifeVantage Corporation (LFVN) +16%.Immunome IMNM...
Gainers: NeuroMetrix (NURO) +161%.NeuroBo Pharmaceuticals (NRBO) +45%.LSB Industries (LXU) +35%.Staffing 360 Solutions (STAF) +24%.Endo International plc (ENDP) +23%.Pop Culture Group (CPOP) +23%.Immunome (IMNM) +19%.Ideal Power (IPWR) +19%.Femasys (FEMY) +16HCA Healthcare (HCA) +15%.Los...
Gainers: NeuroMetrix (NURO) +161%.NeuroBo Pharmaceuticals (NRBO) +45%.LSB Industries (LXU) +35%.Staffing 360 Solutions (STAF) +24%.Endo International plc (ENDP) +23%.Pop Culture Group (CPOP) +23%.Immunome (IMNM) +19%.Ideal Power (IPWR) +19%.Femasys (FEMY) +16HCA Healthcare (HCA) +15%.Los...
First in Class Insemination Treatment for Infertility LOCAL Pivotal Trial to Enroll Up to 792 Patients Across 20 U.S. Centers ATLANTA, July 20, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on transforming women's healthcare, today anno...
Femasys Inc. (NASDAQ:FEMY) traded today at a new 52-week low of $6.83. This new low was reached on above average trading volume as 578,000 shares traded hands, while the average 30-day volume is approximately 239,000 shares. Potential upside of 9.2% exists for Femasys Inc., based on a cu...
Femasys has the potential to transform both birth control and infertility, both of which are multibillion-dollar markets. The company has received a $50mil investment from Medtronic and more recently, existing investors bought into the IPO. Commercialization of FemaSeed will be he...
Shares of Femasys Inc. (NASDAQ:FEMY) traded today at $8.34, breaking its 52-week low. Approximately 255,000 shares have changed hands today, as compared to an average 30-day volume of 0,000 shares. In the past 52 weeks, shares of Femasys Inc. have traded between the current low of $8.34 ...
Shares of Femasys Inc. (NASDAQ:FEMY) traded at a new 52-week low today of $9.65. So far today approximately 117,000 shares have been exchanged, as compared to an average 30-day volume of 0,000 shares. Femasys Inc is a biomedical company focused on transforming women's healthcare by devel...
News, Short Squeeze, Breakout and More Instantly...
ATLANTA, June 27, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic products, announces it will be partici...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 3.5% to $130.78 on volume of 504,910,586 shares Nikola Corporation (NKLA) fell 31.5% to $0.3296 on volume of 265,124,783 shares SMX (Security Matters) Public Limited Company (SMX) rose 35.1% to $0.1608 o...
ATLANTA, June 20, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic products, announces it has received it...